Page 151 - வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Repairing faulty drains could be key to unlocking the potential of Alzheimer s therapies

Repairing faulty drains could be key to unlocking the potential of Alzheimer s therapies Experimental Alzheimer s drugs have shown little success in slowing declines in memory and thinking, leaving scientists searching for explanations. But new research in mice has shown that some investigational Alzheimer s therapies are more effective when paired with a treatment geared toward improving drainage of fluid -; and debris -; from the brain, according to a study led by researchers at Washington University School of Medicine in St. Louis. The findings, published April 28 in the journal Nature, suggest that the brain s drainage system -; known as the meningeal lymphatics -; plays a pivotal but underappreciated role in neurodegenerative disease, and that repairing faulty drains could be a key to unlocking the potential of certain Alzheimer s therapies.

David holtzmanJonathan kipnisGretchenp jonesCarlos cruchagaOscar harariEdithl wolffEmily hendersonPuretech healthDepartment of neurologyStudy coWashington university school of medicineWashington university schoolDistinguished professorStudy co authorடேவிட் ஹோல்ட்ஸ்மேன்ஜொனாதன் கிப்னிச்

First ever FDA-approved brain-computer interface targets stroke rehab

Neurolutions 2/2 The device wirelessly measure brain activity and, via a tablet, communicates with a hand brace allowing stroke patients to regain movement in a paralyzed hand Neurolutions A novel device designed to help stroke patients recover wrist and hand function has been approved by the US Food and Drug Administration (FDA). Called IpsiHand, the system is the first brain-computer interface (BCI) device to ever receive FDA market approval. The IpsiHand device consists of two separate parts – a wireless exoskeleton that is positioned over the wrist, and a small headpiece that records brain activity using non-invasive electroencephalography (EEG) electrodes. The system is based on a discovery made by Eric Leuthardt and colleagues at the Washington University School of Medicine over a decade ago.

United statesEric leuthardtDrug administrationWashington university school of medicineCalled ipsihandWashington university schoolஒன்றுபட்டது மாநிலங்களில்வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்துவாஷிங்டன் பல்கலைக்கழகம் பள்ளி

How COVID derails fight against TB, measles, polio

Major study confirms increased risk of death, serious illness among COVID-19 survivors Pregnant women with pandemic face high mortality rate, 11% of babies contracts virus from their mothers Babies of women infected with coronavirus more likely to be born preterm, researchers find WHO, UNICEF, Gavi highlight urgent need for renewed global commitment to improve vaccination access, uptake A recent study published in the journal Nature showed that COVID-19 pandemic has derailed the fight against other dangerous diseases such as tuberculosis, measles, polio, malaria and Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS). According to the Nature, after India went into lockdown in March 2020, the number of new tuberculosis (TB) cases detected there each day dropped by an alarming 70 per cent in one month.

City ofUnited kingdomUnited statesDemocratic republic of the congoSierra leoneZiyad al alyLucica ditiuAlbert sabinTedros adhanom ghebreyesusAidan olearyMichael gravettBalcha masreshaMeseret zelalemNimalan arinaminpathyJames goodsonPascal mkanda

PureTech talks breakthroughs in Alzheimer s disease treatment

PureTech talks breakthroughs in Alzheimer s disease treatment
outsourcing-pharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outsourcing-pharma.com Daily Mail and Mail on Sunday newspapers.

Jonathan kipnisJoe bolenWashington university school of medicineWashington university schoolஜொனாதன் கிப்னிச்ஓஹோ போலென்வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்துவாஷிங்டன் பல்கலைக்கழகம் பள்ளி

Stroke-recovery device using brain-computer interface receives FDA market authorization | The Source

Innovative multidisciplinary research at Washington University led to development of breakthrough device Eric Leuthardt, MD, professor of neurosurgery at Washington University School of Medicine, models a device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds. Called the IpsiHand Upper Extremity Rehabilitation System, the first-of-its-kind device has received market authorization from the Food and Drug Administration. It was developed by Neurolutions Inc., a Washington University startup company that leverages brain-computer interface technology licensed from the university. (Photo: Elizabethe Holland Durando/School of Medicine) April 27, 2021 SHARE A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration (FDA). The IpsiHand Upper Extremity Rehabil

Joseph humphriesFred khosraviEric leuthardtDaniel moranDavid bundyKern bhugraKim wisneskiTara butlerAlexandre carterLeo petrossianNeurolutions incDepartment of neurologyMckelvey school of engineeringDrug administrationWashington university office of technology managementWashington university school of medicine